Bristol Myers director Bhatt awarded 3,996 DSUs

Bristol Myers Squibb director Deepak Bhatt reported an award of 3,996.367 Deferred Share Units on February 1, 2026, at a reference price of $55.05 per unit.

Rhea-AI Filing Summary

Bristol Myers Squibb director Deepak Bhatt reported an award of 3,996.367 Deferred Share Units on February 1, 2026, at a reference price of $55.05 per unit. After this transaction, he beneficially owned 19,241.818 Deferred Share Units held directly.

Each Deferred Share Unit will convert into one share of Bristol Myers Squibb common stock upon settlement. These units become settleable when Bhatt ceases to be a director or at a future date he previously specified, and the total includes deferred compensation and dividends reinvested under the company’s 1987 Deferred Compensation Plan for Non-Employee Directors.

Insider Trade Summary

Grant/Award: 3,996.367 shares

Grant/Award 1 txn

Insider Bhatt Deepak

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	3,996.367	$55.05	$220K

Holdings After Transaction: Deferred Share Units — 19,241.818 contracts (Direct)

Footnotes (2)

1. F1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
2. F2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Deepak Bhatt report for Bristol Myers Squibb (BMY)?

Deepak Bhatt reported receiving 3,996.367 Deferred Share Units of Bristol Myers Squibb on February 1, 2026. These units are a form of deferred equity compensation granted to him as a director, based on a reference price of $55.05 per unit.

How many Bristol Myers Squibb (BMY) Deferred Share Units does Deepak Bhatt now hold?

After the reported transaction, Deepak Bhatt beneficially owned 19,241.818 Deferred Share Units of Bristol Myers Squibb. This total reflects the new grant plus previously held units, including deferred compensation amounts and dividends reinvested under the company’s non-employee director plan.

When will Deepak Bhatt’s Bristol Myers Squibb (BMY) Deferred Share Units be settled?

Each Deferred Share Unit will be converted into one share of Bristol Myers Squibb common stock upon settlement. The units become settleable when Bhatt ceases to be a director or at a future date he previously specified under the company’s deferred compensation arrangements.

What does one Deferred Share Unit represent for Bristol Myers Squibb (BMY)?

Each Bristol Myers Squibb Deferred Share Unit represents the right to receive one share of common stock upon settlement. The filing states that each unit will be converted into a share of common stock when settled, linking the director’s deferred compensation directly to the company’s equity.

What plan governs Deepak Bhatt’s Deferred Share Units at Bristol Myers Squibb (BMY)?

Bhatt’s Deferred Share Units are linked to the 1987 Deferred Compensation Plan for Non-Employee Directors. The filing notes that his holdings include deferred compensation and dividends reinvested under this plan, which provides equity-based compensation for non-employee members of the board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bhatt Deepak

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NJ 08543

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	02/01/2026		A		3,996.367		(1)	(1)	Common Stock, $0.10 par value	3,996.367	$55.05	19,241.818(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Amy Fallone, attorney-in-fact for Deepak Bhatt	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.